Osteoporosis News and Research

Latest Osteoporosis News and Research

$Connection between depression and loss of bone mass leads to osteoporosis and fractures$

Connection between depression and loss of bone mass leads to osteoporosis and fractures

Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures.

9 Nov 2009

AARP urge Idaho's U.S. Representatives to support health care reform legislation

As the debate over health care reform reaches a fevered pitch and the House readies to vote on critical health care reform legislation in the coming days - AARP is calling on Idaho's U.S. Representatives to support the bill. The AARP-backed Affordable Health Care for America Act (H.R. 3962), which will close the Medicare prescription drug "doughnut hole" and tackle soaring insurance premiums, serves to help hundreds of thousands of Idahoans.

6 Nov 2009

Citracal Calcium plus Heart Health helps support bone and heart health in women

Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.

6 Nov 2009

Pfizer extends JAK3 research collaboration with Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.

6 Nov 2009

Majority of women smokers unaware of immediate and long term health risks

Many women are aware that smoking can lead to lung cancer, heart disease and premature death. But a recent survey conducted by Angus Reid on behalf of nicotine replacement therapy brands, NICODERM(R) and NICORETTE(R) reveals that the majority of Canadian women who smoke are not necessarily aware of the host of other impacts that smoking can have on their immediate and longer term health.

4 Nov 2009

Canadian patients have less access to the latest medicines, says report

Canadian patients have less access to the latest medicines when compared to the world's developed countries, concludes a comprehensive new report released today. The Report shows Canada ranks 20th out of 25 OECD countries in public reimbursement of new drug therapies. Canada's grade of 56% is comparable with Iceland, Slovakia and Turkey.

4 Nov 2009

New medical guidelines for accurate diagnosis and ethical treatment of growth hormone deficiency

Today the American Association of Clinical Endocrinologists (AACE) released new medical guidelines for the accurate diagnosis and effective ethical treatment of growth hormone deficiency in affected patients.

4 Nov 2009

$Aggressive osteoporosis prevention could reduce hip fracture rate in the U.S. by 25%: Study$

Aggressive osteoporosis prevention could reduce hip fracture rate in the U.S. by 25%: Study

Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.

3 Nov 2009

Enzo Biochem announces results of EGS21 clinical trial for treatment of non-alcoholic steatohepatitis

Enzo Biochem Inc. announced today that favorable results of the Company’s clinical trial for treatment of non-alcoholic steatohepatitis (NASH) were presented at the annual meeting of the American Association for the Study of Liver Diseases. The study was a randomized double blind placebo controlled format of EGS21, Enzo’s orally administered beta glucosylceramide formulation, designed to evaluate safety and efficacy of the study drug in patients with NASH and its associated metabolic syndrome.

2 Nov 2009

Ligand Pharmaceuticals amends license agreement with Exelixis

Ligand Pharmaceuticals Incorporated has amended its license agreement with Exelixis, Inc. as a result of which Ligand is now entitled to receive royalties on net sales of future products from a mineralocorticoid receptor program and a one-time $75,000 payment for providing access to certain patent rights.

2 Nov 2009

Soundview Medical Associates chooses Allscripts' EHR and PM for better management

Allscripts announced today that Soundview Medical Associates has selected Allscripts Electronic Health Record (EHR) and Practice Management (PM) to enhance the quality of the care delivered by its 22 physicians, improve patient communications, and better manage the cost of care delivery.

30 Oct 2009

USANA’s Active Calcium Chewable supplement improves bone health in young girls

USANA Health Sciences, Inc. announced today that a third-party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA’s Active Calcium™ Chewable supplement improves bone health in young girls.

30 Oct 2009

Interleukin Genetics and Amway Global sign partnership agreement

Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.

29 Oct 2009

Steroid-induced osteoporosis can now be treated with Teriparatide

A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid-induced OP who were treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.

29 Oct 2009

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease.

28 Oct 2009

GI Solutions to conduct new incision-free procedure for GERD patients

Chicago woman will be among the first in the country to undergo a new incision-less, endoscopic procedure that could get rid of Gastrointestinal Esophageal Reflux Disease (GERD) forever.

27 Oct 2009

Physicians launch SUCCEED, program for breast cancer survivors

Breast cancer. A diagnosis of those two words elicits an array of emotions ranging from fear and anger, to confusion and uncertainty. To cope, women often look to family, friends and survivors for support, forming a network of people to help guide them through their diagnosis and treatment. As treatment begins, the plan seems clear.

27 Oct 2009

$Cardiovascular disease may increase hip fracture incidence$

Cardiovascular disease may increase hip fracture incidence

A study that includes twins finds that the risk of hip fracture was significantly increased following a diagnosis of cardiovascular disease (CVD), with analysis also suggesting a genetic predisposition to the development of CVD and fractures, according to a study in the October 21 issue of JAMA.

26 Oct 2009

Nutri5, an effective natural product for the relief of menopausal symptoms

Earlier this year, the BBC reported that "HRT - Hormone Replacement Therapy - can shrink women's brains"1, after a study was published which showed that brain volume in women taking HRT was smaller in two key areas involved in thinking and memory.

23 Oct 2009

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

The United States Bone and Joint Decade (USBJD) today announces that as part of its 2009 Advocacy Day nearly 80 musculoskeletal patients and patient advocates from across the nation are participating in more than 175 Congressional visits. Patients and their advocates -- physicians, family members and USBJD participating partners -- are raising awareness of the huge burden that musculoskeletal conditions plays on the U.S. These conditions are some of the most costly, common, and disabling conditions to date.

22 Oct 2009

Osteoporosis News and Research

Latest Osteoporosis News and Research

Connection between depression and loss of bone mass leads to osteoporosis and fractures

AARP urge Idaho's U.S. Representatives to support health care reform legislation

Citracal Calcium plus Heart Health helps support bone and heart health in women

Pfizer extends JAK3 research collaboration with Ligand Pharmaceuticals

Majority of women smokers unaware of immediate and long term health risks

Canadian patients have less access to the latest medicines, says report

New medical guidelines for accurate diagnosis and ethical treatment of growth hormone deficiency

Aggressive osteoporosis prevention could reduce hip fracture rate in the U.S. by 25%: Study

Enzo Biochem announces results of EGS21 clinical trial for treatment of non-alcoholic steatohepatitis

Ligand Pharmaceuticals amends license agreement with Exelixis

Soundview Medical Associates chooses Allscripts' EHR and PM for better management

USANA’s Active Calcium Chewable supplement improves bone health in young girls

Interleukin Genetics and Amway Global sign partnership agreement

Steroid-induced osteoporosis can now be treated with Teriparatide

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

GI Solutions to conduct new incision-free procedure for GERD patients

Physicians launch SUCCEED, program for breast cancer survivors

Cardiovascular disease may increase hip fracture incidence

Nutri5, an effective natural product for the relief of menopausal symptoms

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Osteoporosis News and Research

Latest Osteoporosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in